Carvedilol Tablet, Film Coated
Product Images NDC 71335-2026

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71335-2026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line graph illustrating cumulative mortality percentages over 24 months for two groups: one treated with Carvedilol and the other with placebo. The x-axis represents time in months, and the y-axis reflects percentage mortality. The graph shows lower mortality rates for the Carvedilol group compared to placebo, with a p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot chart showing hazard ratios for different patient subgroups, including gender, age groups, race, diabetic status, ischemic status, heart rate categories, systolic blood pressure categories, and use of spironolactone. The x-axis represents hazard ratio values from 0 to 2, with a reference line at 1.0, indicating the comparison of risk across subgroups.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line chart depicting percent mortality over 24 months comparing Carvedilol and placebo groups. The x-axis represents time in months, and the y-axis shows percent mortality. The Carvedilol group demonstrates lower mortality rates than the placebo group throughout the study period, with a significance value of P = 0.03 indicated.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A forest plot displaying hazard ratios related to various patient subgroups including age, gender, timing after myocardial infarction, use of beta blockers, Killip classification, thrombolytic therapy, PTCA, heart failure history, diuretics use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The plot compares these subgroups across two panels, each showing hazard ratios with confidence intervals plotted around a reference line at 1.0.*

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure of carvedilol, depicting its molecular arrangement with labeled functional groups and bonds as commonly represented in pharmaceutical chemistry.*

FDA Label Image

Label (Lbl713352026)

Label for Carvedilol 12.5 mg tablet, film coated, packaged by Bryant Ranch Prepack in Burbank, CA. The label includes storage instructions at 20°-25°C (68°-77°F), a warning to keep drugs out of reach of children, and a barcode. It references comparison to Coreg 12.5 mg tablet by Rubicon Research Private Limited, with a package quantity of 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.